BioMarin 製藥公司
DE ˙ DB ˙ US09061G1013
€46.59 ↑0.90 (1.97%)
2026-06-04
分享價格
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionWestpac Banking Corp
Latest Disclosed Ownership12,997 shares
Latest Disclosed Value $ 734,201
Westpac Banking Corp reports 49.27% decrease in ownership of BM8 / BioMarin Pharmaceutical Inc.

On May 11, 2026 - Westpac Banking Corp filed a 13F-HR form disclosing ownership of 12,997 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $623,596 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 25,621 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -49.27% during the quarter. The current value of the position is $605,530 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,997 -12,624 -49.27 734 -51.77 0.0256
2026-02-10 2025-12-31 13F BIOMARIN PHARMACEUTICAL INC USD 0.001 COM 09061G101 25,621 20,747 425.67 1,523 478.71 0.0962
2025-11-14 2025-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL INC USD 0.001 COM 09061G101 4,874 -9,106 -65.14 264 -65.76 0.0164
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL INC USD 0.001 COM 09061G101 4,874 -9,106 264 0.0066
2025-08-11 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,980 13,980 768 0.0514
2025-05-13 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -3,501 -100.00 0 -100.00
2025-02-12 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,501 1,414 67.75 230 57.53 0.0153
2024-11-08 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,087 0 0.00 147 -14.62 0.0098
2024-08-14 2024-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 2,087 0 0.00 172 -6.04 0.0136
2024-08-13 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 82 -2,005 172 0.0059
2024-05-09 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,087 0 0.00 182 -9.45 0.0139
2024-02-08 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,087 735 54.36 201 68.91 0.0166
2023-11-13 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,352 0 0.00 120 1.71 0.0090
2023-08-10 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,352 -16,102 -92.25 117 -93.11 0.0083
2023-05-04 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,454 3,923 28.99 1,697 21.21 0.0228
2023-02-06 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,531 355 2.69 1,400 25.45 0.0207
2022-11-08 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,176 0 0.00 1,117 2.29 0.0170
2022-08-10 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,176 0 0.00 1,092 7.49 0.0142
2022-05-11 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,176 0 0.00 1,016 -12.80 0.0117
2022-02-08 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM CL A 09061G101 13,176 997 8.19 1,164 23.70 0.0121
2021-10-27 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 941 -7.38 0.0101
2021-08-11 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 1,016 10.55 0.0102
2021-05-13 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 920 -13.87 0.0101
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 1,068 15.23 0.0121
2020-11-10 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 927 -38.35 0.0126
2020-08-12 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 1,502 45.97 0.0224
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 1,029 0.00 0.0177
2020-02-11 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 1,030 25.49 0.0133
2019-11-13 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 821 -21.38 0.0114
2019-08-01 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 1,043 -3.52 0.0159
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 0 0.00 1,082 4.24 0.0179
2019-02-07 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,179 2,161 21.57 1,037 6.80 0.0177
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,018 0 0.00 971 2.97 0.0167
2018-07-18 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,018 0 0.00 944 16.13 0.0181
2018-05-01 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,018 0 0.00 812 -9.07 0.0162
2018-01-18 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,018 0 0.00 893 -4.18 0.0203
2017-10-30 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,018 0 0.00 932 2.53 0.0205
2017-08-09 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,018 -3,281 -24.67 910 -22.11 0.0200
2017-05-18 2017-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 13,299 -6 -0.05 1,167 5.52 0.0094
2017-05-11 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,158 855
2017-02-09 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,305 499 3.90 1,107 -6.59 0.0104
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,806 3,879 43.45 1,185 70.61 0.0128
2016-08-10 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,927 2,050 29.81 695 22.40 0.0076
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,877 -2,633 -27.69 567 -43.07 0.0062
2016-02-11 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,510 -42,667 -81.77 996 -81.87 0.0110
2015-11-16 2015-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 52,177 -46,684 -47.22 5,495 -59.36 0.0605
2015-11-12 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 52,177 5,495
2015-08-12 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 98,861 84,993 612.87 13,522 624.65 0.1322
2015-05-12 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,868 -1,550 -10.05 1,867 33.96 0.0162
2015-02-11 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,418 434 2.90 1,394 28.86 0.0133
2014-11-12 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,984 5,399 56.33 1,081 81.38 0.0105
2014-08-11 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,585 -140 -1.44 596 -10.11 0.0057
2014-05-12 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,725 1,100 12.75 663 9.41 0.0071
2014-02-13 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,625 181 2.14 606 -0.49 0.0069
2013-11-12 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,444 2,544 43.12 610 85.11 0.0076
2013-08-14 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,900 5,900 329 0.0050
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.